Corrigendum: Efficacy and safety of riociguat replacing PDE-5is for patients with pulmonary arterial hypertension: A systematic review and meta-analysis

Frontiers in Pharmacology

Pharmacology

Rui Zhang¹  Hong-Ling Qiu²  Shang Wang²  Yi-Yang Qu²  Hui-Ting Li²  Ci-Jun Luo²  Ping Yuan²  Rong Jiang²  Lan Wang²  Yu-Yang Liu²  Jin-Ling Li³ 

[1] Department of Cardiology, Affiliated Hospital of Qingdao University, Qingdao, China;Department of Cardiopulmonary Circulation, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China;Department of Cardiopulmonary Circulation, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China;Department of Cardiology, Affiliated Hospital of Qingdao University, Qingdao, China;

关键词: pulmonary arterial hypertension;    riociguat;    systematic review;    meta, analysis;    phosphodiesterase-5 inhibitor;   

DOI  :  10.3389/fphar.2023.1155631

 received in 2023-01-31, accepted in 2023-02-13,  发布年份 2023

来源: Frontiers

【 授权许可】

Unknown   
Copyright © 2023 Liu, Qu, Wang, Luo, Qiu, Li, Yuan, Wang, Li, Jiang and Zhang.